Jan Vaage

2.1k total citations
72 papers, 1.7k citations indexed

About

Jan Vaage is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jan Vaage has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 23 papers in Molecular Biology and 22 papers in Immunology. Recurrent topics in Jan Vaage's work include Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (14 papers) and Nanoparticle-Based Drug Delivery (14 papers). Jan Vaage is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (14 papers) and Nanoparticle-Based Drug Delivery (14 papers). Jan Vaage collaborates with scholars based in United States and United Kingdom. Jan Vaage's co-authors include E. Mayhew, Peter K. Working, Paul S. Uster, R.M. Abra, Anthony H. C. Huang, William J. Lindblad, Frank Martin, D. D. Lasic, Emilio Barberá‐Guillem and S.K. Huang and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jan Vaage

71 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Vaage United States	22	680	520	493	409	211	72	1.7k
Nely Wigler Israel	10	870 1.3×	424 0.8×	645 1.3×	212 0.5×	118 0.6×	17	1.9k
Takanori Kawaguchi Japan	22	331 0.5×	588 1.1×	202 0.4×	213 0.5×	137 0.6×	77	1.5k
Craig Tendler United States	14	928 1.4×	509 1.0×	713 1.4×	640 1.6×	133 0.6×	25	2.5k
Robert S. Greenfield United States	17	334 0.5×	480 0.9×	215 0.4×	241 0.6×	388 1.8×	43	1.3k
Gail Colbern United States	14	310 0.5×	707 1.4×	795 1.6×	161 0.4×	213 1.0×	20	1.5k
Edward Pearlstein United States	26	505 0.7×	789 1.5×	119 0.2×	282 0.7×	281 1.3×	46	2.5k
G. Hartung Germany	17	781 1.1×	494 0.9×	202 0.4×	225 0.6×	142 0.7×	57	1.6k
Lou F. M. H. de Leij Netherlands	26	454 0.7×	1.1k 2.1×	117 0.2×	571 1.4×	190 0.9×	57	2.1k
M F Poupon France	22	607 0.9×	620 1.2×	238 0.5×	149 0.4×	63 0.3×	48	1.5k
Erlinda M. Gordon United States	35	951 1.4×	1.3k 2.4×	150 0.3×	271 0.7×	282 1.3×	154	3.1k

Countries citing papers authored by Jan Vaage

Since Specialization

Citations

This map shows the geographic impact of Jan Vaage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Vaage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Vaage more than expected).

Fields of papers citing papers by Jan Vaage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Vaage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Vaage. The network helps show where Jan Vaage may publish in the future.

Co-authorship network of co-authors of Jan Vaage

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Vaage. A scholar is included among the top collaborators of Jan Vaage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Vaage. Jan Vaage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vaage, Jan, et al.. (1999). Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes. International Journal of Cancer. 80(1). 134–137. 40 indexed citations

Vaage, Jan, Peter K. Working, & Paul S. Uster. (1998). Inhibition of mouse mammary carcinoma development with doxorubicin in liposomes. International Journal of Cancer. 75(1). 158–159. 1 indexed citations

Vaage, Jan, et al.. (1997). Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. British Journal of Cancer. 75(4). 482–486. 89 indexed citations

Vaage, Jan, et al.. (1995). Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. British Journal of Cancer. 72(5). 1074–1075. 11 indexed citations

Vaage, Jan, Emilio Barberá‐Guillem, R.M. Abra, Anthony H. C. Huang, & Peter K. Working. (1994). Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer. 73(5). 1478–1484. 133 indexed citations

Vaage, Jan, et al.. (1993). Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. International Journal of Cancer. 54(6). 959–964. 57 indexed citations

Vaage, Jan. (1992). Immunologic aspects of fibrosis in mouse mammary carcinomas. International Journal of Cancer. 50(1). 69–74. 8 indexed citations

Vaage, Jan. (1992). Fibrosis in immune control of mammary‐tumor growth. International Journal of Cancer. 51(2). 325–328. 16 indexed citations

Vaage, Jan & E. Mayhew. (1991). Immunotherapy of a mouse mammary carcinoma by sustained peritumor release of IL‐2. International Journal of Cancer. 47(4). 582–585. 20 indexed citations

10.

Vaage, Jan & J. P. Harlos. (1991). Collagen production by macrophages in tumour encapsulation and dormancy. British Journal of Cancer. 63(5). 758–762. 24 indexed citations

11.

Vaage, Jan, et al.. (1991). Normal inhibition of mammary tumor metastasis in C3H/He mice. Clinical & Experimental Metastasis. 9(3). 273–281. 1 indexed citations

12.

Vaage, Jan. (1991). Peri‐tumor interleukin‐2 causes systemic therapeutic effect via interferon‐γ induction. International Journal of Cancer. 49(4). 598–600. 14 indexed citations

13.

Vaage, Jan. (1989). A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors. International Journal of Cancer. 43(5). 910–914. 5 indexed citations

14.

Vaage, Jan. (1989). Loss of spontaneous metastasizing potential in mouse mammary tumors. Clinical & Experimental Metastasis. 7(3). 373–378. 5 indexed citations

15.

Vaage, Jan. (1978). A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2). 331–8. 26 indexed citations

16.

Vaage, Jan & Sudha Agarwal. (1977). Serum therapy for radiation-induced impairment of immune resistance to metastasis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(10). 3556–60. 5 indexed citations

17.

Vaage, Jan, et al.. (1974). Radiation-induced changes in established tumor immunity.. PubMed. 34(1). 129–37. 17 indexed citations

18.

Vaage, Jan. (1973). Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.. PubMed. 33(8). 1957–65. 22 indexed citations

19.

Vaage, Jan. (1972). Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.. PubMed. 32(2). 193–9. 37 indexed citations

20.

Vaage, Jan, et al.. (1971). Effect of immune status on the development of artificially induced metastases in different anatomical locations.. PubMed. 31(5). 496–500. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact